Juul Labs has received authorization from the US Food and Drug Administration to keep selling its e-cigarettes, including its original device and tabacco and methol refill pods, The Wall Street Journal reported Thursday, citing people familiar with the matter.

The decision comes five years after Juul first submitted its products for federal review, the report said.

The approval marks a key turnaround for the company, which was nearly pushed into bankruptcy after the FDA ordered a sales ban in 2022 due to unresolved concerns about its toxicology data. Although that ban was quickly put on hold, it triggered a financial crisis and waves of lawsuits, according to the report.

Juul Labs and the FDA didn't immediately reply to MT Newswires' requests for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 58.02, Change: -0.84, Percent Change: -1.44